Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...
Modern businesses run on data. Companies regularly capture, store and analyze large amounts of quantitative and qualitative data on consumer behavior, to which they can apply predictive analytics to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results